These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1136 related items for PubMed ID: 31793871
1. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease . Yin C, Cheng C, Wang J, Zhang L, Purrunsing Y, Yang G, Zeng M, Huang H, Ren W, Ye Y, Ma H, Xing C, Wang N. Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871 [Abstract] [Full Text] [Related]
3. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome]. Hu S, Wang D, Zhang R, Cao Y, Jin H, Mao Y, Wei L, Ren K, Zhang X, Wang Y. Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec 30; 38(12):1427-1432. PubMed ID: 30613009 [Abstract] [Full Text] [Related]
4. Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease. Hong YA, Lim JH, Kim MY, Kim Y, Yang KS, Chung BH, Chung S, Choi BS, Yang CW, Kim YS, Chang YS, Park CW. Clin Exp Nephrol; 2015 Apr 30; 19(2):208-15. PubMed ID: 24682550 [Abstract] [Full Text] [Related]
5. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease. Parker VJ, Harjes LM, Dembek K, Young GS, Chew DJ, Toribio RE. J Vet Intern Med; 2017 May 30; 31(3):791-798. PubMed ID: 28186657 [Abstract] [Full Text] [Related]
6. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers . Lima F, Mawad H, El-Husseini AA, Davenport DL, Malluche HH. Clin Nephrol; 2019 Apr 30; 91(4):222-230. PubMed ID: 30862350 [Abstract] [Full Text] [Related]
7. Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients. Pietrzyk B, Wyskida K, Ficek J, Kolonko A, Ficek R, Więcek A, Olszanecka-Glinianowicz M, Chudek J. Int Urol Nephrol; 2019 Mar 30; 51(3):519-526. PubMed ID: 30584645 [Abstract] [Full Text] [Related]
8. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease. Liu Z, Zhou H, Chen X, Chen H, Wang Y, Wang T, Cai L, Hong Y, Ke H, Zheng J. Int Urol Nephrol; 2019 Mar 30; 51(3):503-507. PubMed ID: 30689182 [Abstract] [Full Text] [Related]
9. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly. Chudek J, Kocełak P, Owczarek A, Bożentowicz-Wikarek M, Mossakowska M, Olszanecka-Glinianowicz M, Wiecek A. Nephrol Dial Transplant; 2014 Sep 30; 29(9):1757-63. PubMed ID: 24729016 [Abstract] [Full Text] [Related]
10. Disordered FGF23 and mineral metabolism in children with CKD. Portale AA, Wolf M, Jüppner H, Messinger S, Kumar J, Wesseling-Perry K, Schwartz GJ, Furth SL, Warady BA, Salusky IB. Clin J Am Soc Nephrol; 2014 Feb 30; 9(2):344-53. PubMed ID: 24311704 [Abstract] [Full Text] [Related]
11. In chronic kidney disease, serum α-Klotho is related to serum bicarbonate and proteinuria. Hage V, Pelletier S, Dubourg L, Drai J, Cuerq C, Lemoine S, Hadj-Aissa A, Laville M, Fouque D. J Ren Nutr; 2014 Nov 30; 24(6):390-4. PubMed ID: 25193108 [Abstract] [Full Text] [Related]
12. Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder? Figurek A, Spasovski G. Int Urol Nephrol; 2018 Oct 30; 50(10):1863-1870. PubMed ID: 30030677 [Abstract] [Full Text] [Related]
13. Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease. Yi HJ, Lee JB, Lee KP, Oh YI, Song KH, Seo KW. BMC Vet Res; 2020 Jul 16; 16(1):246. PubMed ID: 32677951 [Abstract] [Full Text] [Related]
15. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease. Strugnell SA, Sprague SM, Ashfaq A, Petkovich M, Bishop CW. Am J Nephrol; 2019 Apr 16; 49(4):284-293. PubMed ID: 30878999 [Abstract] [Full Text] [Related]
16. Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study. Lin CH, Chang CK, Shih CW, Li HY, Chen KY, Yang WS, Tsai KS, Wang CY, Shih SR. Osteoporos Int; 2019 Nov 16; 30(11):2289-2297. PubMed ID: 31384956 [Abstract] [Full Text] [Related]
17. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Shimamura Y, Hamada K, Inoue K, Ogata K, Ishihara M, Kagawa T, Inoue M, Fujimoto S, Ikebe M, Yuasa K, Yamanaka S, Sugiura T, Terada Y. Clin Exp Nephrol; 2012 Oct 16; 16(5):722-9. PubMed ID: 22457086 [Abstract] [Full Text] [Related]
18. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease. Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R. Nephrol Dial Transplant; 2013 Jan 16; 28(1):153-61. PubMed ID: 23180879 [Abstract] [Full Text] [Related]